Raxitkumar Jinjuvadia1, Augustine Salami1, Adrienne Lenhart1, Kartikkumar Jinjuvadia2, Suthat Liangpunsakul3, Reena Salgia4. 1. Division of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, Michigan. 2. Division of Gastroenterology and Hepatology, Wayne State University, Detroit, Michigan. 3. Division of Gastroenterology/Hepatology, Roudebush Veterans Administration Medical Center, Indiana University School of Medicine, Indianapolis, Indiana; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana. 4. Division of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, Michigan. Electronic address: rsalgia1@hfhs.org.
Abstract
BACKGROUND: Despite a rise in the prevalence of hepatocellular carcinoma (HCC), data on HCC-related hospitalizations and financial burden are limited. The aim of this study was to evaluate temporal trends of HCC-related hospitalizations and evaluate its financial influence. MATERIALS AND METHODS: Patients with the diagnosis of HCC, as reported by International Classification of Diseases-Ninth Revision code, were identified from the National Inpatient Sample databases from 2002-2011. The national estimates of hospitalizations were derived using appropriate sample weights. The change in total average charges per each hospitalization over the study period was calculated after adjusting for inflation. RESULTS: Hospitalizations related to HCC have increased from 24,024 in 2002 to 50,609 in 2011. Of these admissions, HCC was the principal diagnosis in 10,762 and 16,350 subjects in 2002 and 2011, respectively. Most were white males (male: 70%; white: 55%). The overall inpatient mortality was significantly decreased from 13.5% in 2002 to 9.9% in 2011 (P < 0.01). The same trend was also observed for the length of hospital stay (6.5 versus 5.6 days in 2002 and 2011, respectively). The inflation-adjusted cost per hospitalization increased by approximately 47% during the study period. CONCLUSIONS: Despite the decrease in mortality rate and length-of-stay, hospitalizations and financial burden associated with HCC continued to increase between 2002 and 2011 in the United States.
BACKGROUND: Despite a rise in the prevalence of hepatocellular carcinoma (HCC), data on HCC-related hospitalizations and financial burden are limited. The aim of this study was to evaluate temporal trends of HCC-related hospitalizations and evaluate its financial influence. MATERIALS AND METHODS:Patients with the diagnosis of HCC, as reported by International Classification of Diseases-Ninth Revision code, were identified from the National Inpatient Sample databases from 2002-2011. The national estimates of hospitalizations were derived using appropriate sample weights. The change in total average charges per each hospitalization over the study period was calculated after adjusting for inflation. RESULTS: Hospitalizations related to HCC have increased from 24,024 in 2002 to 50,609 in 2011. Of these admissions, HCC was the principal diagnosis in 10,762 and 16,350 subjects in 2002 and 2011, respectively. Most were white males (male: 70%; white: 55%). The overall inpatient mortality was significantly decreased from 13.5% in 2002 to 9.9% in 2011 (P < 0.01). The same trend was also observed for the length of hospital stay (6.5 versus 5.6 days in 2002 and 2011, respectively). The inflation-adjusted cost per hospitalization increased by approximately 47% during the study period. CONCLUSIONS: Despite the decrease in mortality rate and length-of-stay, hospitalizations and financial burden associated with HCC continued to increase between 2002 and 2011 in the United States.
Authors: Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin Journal: Int J Cancer Date: 2010-12-15 Impact factor: 7.396
Authors: Robert Rogers; Taylor F Eagle; Anne Sheetz; Alan Woodward; Robert Leibowitz; MinKyoung Song; Rachel Sylvester; Nicole Corriveau; Eva Kline-Rogers; Qingmei Jiang; Elizabeth A Jackson; Kim A Eagle Journal: Child Obes Date: 2015-11-12 Impact factor: 2.992
Authors: Vishal Singh; Beng San Yeoh; Ahmed A Abokor; Rachel M Golonka; Yuan Tian; Andrew D Patterson; Bina Joe; Mathias Heikenwalder; Matam Vijay-Kumar Journal: Gut Microbes Date: 2020-03-30